Bayer BAYRY's wholly owned subsidiary, AskBio Inc., announced the completion of patient enrollment in the mid-stage GenePHIT study evaluating AB-1002 for heart failure with reduced ejection fraction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results